Paragon Care (PGC) Stock Overview
Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
PGC Community Fair Values
Create NarrativeSee what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.
Paragon Care Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.25 |
| 52 Week High | AU$0.59 |
| 52 Week Low | AU$0.24 |
| Beta | 0 |
| 1 Month Change | -21.88% |
| 3 Month Change | -24.24% |
| 1 Year Change | -47.37% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -35.90% |
Recent News & Updates
Recent updates
Asia Pacific Expansion And Healthcare Diversification Will Drive Future Success
Key Takeaways Expansion into high-growth Asia-Pacific markets and targeting demographic-driven healthcare demand are expected to drive sustainable long-term revenue and margin growth. Acquisitions integration, investment in higher-margin areas, and improved cost structures are set to enhance profitability and operational efficiency.Paragon Care Limited's (ASX:PGC) Share Price Matching Investor Opinion
Aug 28
Paragon Care Limited (ASX:PGC) Shares Could Be 23% Above Their Intrinsic Value Estimate
Jan 31A Look At The Fair Value Of Paragon Care Limited (ASX:PGC)
Oct 22Paragon Care's (ASX:PGC) Soft Earnings Are Actually Better Than They Appear
Oct 01Shareholder Returns
| PGC | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | -16.7% | -0.3% | 0.6% |
| 1Y | -47.4% | -13.1% | 1.2% |
Return vs Industry: PGC underperformed the Australian Healthcare industry which returned -13.1% over the past year.
Return vs Market: PGC underperformed the Australian Market which returned 1.2% over the past year.
Price Volatility
| PGC volatility | |
|---|---|
| PGC Average Weekly Movement | 7.1% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 9.5% |
| 10% most volatile stocks in AU Market | 18.9% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: PGC has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: PGC's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Carmen Riley | www.paragoncare.com.au |
Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, breast milk tracking, electrodes; sterilisable transducers designed for surgical procedures, digital theatre integration, infection control, infusion therapy, temperature management, enteral feeding, pain management, lasers, operating room products, surgical consumables, and ultrasound systems.
Paragon Care Limited Fundamentals Summary
| PGC fundamental statistics | |
|---|---|
| Market cap | AU$438.66m |
| Earnings (TTM) | AU$20.57m |
| Revenue (TTM) | AU$3.61b |
Is PGC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PGC income statement (TTM) | |
|---|---|
| Revenue | AU$3.61b |
| Cost of Revenue | AU$3.29b |
| Gross Profit | AU$324.00m |
| Other Expenses | AU$303.43m |
| Earnings | AU$20.57m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.012 |
| Gross Margin | 8.97% |
| Net Profit Margin | 0.57% |
| Debt/Equity Ratio | 71.2% |
How did PGC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/03 15:44 |
| End of Day Share Price | 2025/12/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Paragon Care Limited is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Hester | Bell Potter |
| Thomas Godfrey | Ord Minnett Limited |